MediWound is Pharmaceuticals in Israel that focus on to-heal wounds business. Founded in 2001. They cover business area such as MediWound Ltd, manufacturing, novel therapeutic product, unmet medical need, severe burn, heal, connective tissue disorder, its first biopharmaceutical product, NexoBrid, dead or damaged tissue, eschar, adult, deep partial- and full-thickness thermal burn, clinical development, North America, its Biologics License Application, its revenue, United States.
2001
( 23 years old in 2024 )
To-heal Wounds
-
42 Hayarkon Street
Yavne 8122745
Israel
Private
MediWound Ltdmanufacturingnovel therapeutic productunmet medical needsevere burnhealconnective tissue disorderits first biopharmaceutical productNexoBriddead or damaged tissueescharadultdeep partial- and full-thickness thermal burnclinical developmentNorth Americaits Biologics License Applicationits revenueUnited States
* We use standard office opening hours in near MediWound's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MediWound is Pharmaceuticals business from Israel that founded in 2001 (23 years old in 2024), MediWound business is focusing on To-heal Wounds.
MediWound headquarter office and corporate office address is located in 42 Hayarkon Street Yavne 8122745 Israel.
MediWound was founded in Israel.
In 2024, MediWound is currently focus on to-heal wounds sector.
Above is snippet of Google Trends for "to-heal wounds" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MediWound, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
